Renasant Bio
Latest round
- Seed
Last raised
- Jun 2025
Total raised
- $30M
Investors
- 4
About Renasant Bio
Renasant Bio, based in the US, is a biotech firm focused on developing innovative therapies for autosomal dominant polycystic kidney disease (ADPKD).Renasant Bio is dedicated to advancing treatments for autosomal dominant polycystic kidney disease (ADPKD). The company is headquartered in Berkeley, US. The firm has had one total deal to date.Renasant Bio specializes in developing disease-modifying therapies for ADPKD through innovative small molecule correctors and potentiators. These products aim to restore the function of key renal proteins, polycystin 1 and 2 (PC1/2), essential for kidney regulation.Renasant Bio’s revenue model hinges on the commercialization of its proprietary therapies aimed at ADPKD. The company partners with healthcare providers and pharmaceutical firms for streamlined access to its products. Revenue is generated as these therapies become available for prescriptions, focusing on oral small molecule formulations that improve patient adherence. The company plans to expand its reach into additional global markets, aiming to enhance access for patients affected by ADPKD.
Who invested in Renasant Bio
4 investors across 1 round
See all investors in Renasant Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 3, 2025
Amount
$30M
Investors
Questions about Renasant Bio
Who invested in Renasant Bio?
Renasant Bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Renasant Bio raised?
Renasant Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Renasant Bio last raise money?
Renasant Bio's most recent round on record is a Seed, in Jun 2025.
What does Renasant Bio do?
Renasant Bio, based in the US, is a biotech firm focused on developing innovative therapies for autosomal dominant polycystic kidney disease (ADPKD).
Where is Renasant Bio headquartered?
Renasant Bio is headquartered in Berkeley, US.
Which VCs invest in companies like Renasant Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Renasant Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Renasant Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.